NCT00702676View on ClinicalTrials.gov

Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

Quetiapine Fumarate

Tablet, Oral, once daily

DRUG

Quetiapine Fumarate

Tablet, Oral, once daily

Trial Locations (1)

Unknown

Research Site, Baltimore

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY